Lyra Therapeutics LYR-220 BEACON Phase 2 Topline Sep 12, 2023 at 8:00 AM EDT Participate in the conference call by telephone - click here Listen to Webcast Supporting Materials BEACON Study Topline Results Investor Presentation 354.8 KB